Catheter ablation of atrial fibrillation in patients with cardiac amyloidosis and sarcoidosis: procedural findings and outcomes
Europace · 03.06.2025 · 27 (6)
DOI: 10.1093/europace/euaf100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, online erschienen am 20.06.2025. Verfasst von Alireza Oraii und 26 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, 1 Conv…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Amyloidosis, Sarcoidosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bogle Family Fund, Translational Lab Research Fund.
Abstract (Originalsprache)
Aims
The diagnosis of infiltrative cardiomyopathies has increased over last years. Catheter ablation is becoming the preferred approach for managing atrial fibrillation (AF) in these patients. This study aims to characterize differences in procedural findings during AF ablation in patients with and without infiltrative cardiomyopathies. Methods and results Patients with cardiac amyloidosis and cardiac sarcoidosis undergoing first-time AF ablation were propensity score matched in 1:4 ratio to separate reference groups that received trigger provocative manoeuvres (isoproterenol infusion and/or atrial burst pacing) and had no prior cardiac surgery. Non-pulmonary vein (PV) triggers [defined as ectopic foci initiating AF or sustained focal atrial tachycardia (AT)] and macro-reentrant atrial flutters (AFLs) were then mapped and targeted. Recurrence was defined as AF/AT/AFL ≥ 30 s after 90-day blanking period. Twenty-four patients with cardiac amyloidosis were matched to 96 controls, and 17 patients with cardiac sarcoidosis were matched to 68 controls. Non-PV triggers were more frequent in patients with cardiac amyloidosis {29.2% vs. 8.3%; odds ratio [OR] = 4.5 [95% confidence interval (CI): 1.4–14.2]} and cardiac sarcoidosis [17.6% vs. 7.4%; OR = 2.7 (95% CI: 0.6–12.6)] compared with their reference groups. Patients with cardiac amyloidosis also had a higher incidence of left atrial macro-reentrant flutters [37.5% vs. 6.3%; OR = 9.0, (95% CI: 2.8–29.0)]. One-year recurrence rate was similar between patients with cardiac sarcoidosis and controls (33.3% vs. 33.9%; P = 0.965) but higher in patients with cardiac amyloidosis vs. controls (47.4% vs. 27.1%; P = 0.049).
Conclusion
Patients with infiltrative cardiomyopathies exhibit higher rates of non-PV triggers and left AFLs during first-time AF ablation. Those with cardiac amyloidosis experience higher arrhythmia recurrence rates compared with controls.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Cardiac Electrophysiology, Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, 1 Convention Ave, Pavilion - 2nd floor City Side, Philadelphia, PA 19104, US…
ORCID-Profile: Alireza Oraii, Balaram Krishna J Hanumanthu, Adrian Petzl, Ting-Wei Liao, Arian Afzalian, Oriol Rodriguez-Queralto, Corentin Chaumont, Jenna Spears, Timothy M Markman, Matthew C Hyman, Cory M Tschabrunn, Gustavo Guandalini, Poojita Shivamurthy, Rajat Deo, Victor A Ferrari, David Lin, David J Callans, Gregory E Supple, Robert D Schaller, David S Frankel, Saman Nazarian, Sanjay Dixit, Francis E Marchlinski
Förderung
- Bogle Family Fund
- Translational Lab Research Fund
Zitieren
APA
Oraii, A., Hanumanthu, B. K. J., Petzl, A., Liao, T. W., Afzalian, A., Rodriguez-Queralto, O., Chaumont, C., Spears, J., Markman, T. M., Hyman, M. C., Tschabrunn, C. M., Guandalini, G., Enriquez, A., Shivamurthy, P., Kumareswaran, R., Deo, R., Ferrari, V. A., Riley, M. P., Lin, D., …, & Marchlinski, F. E. (2025). Catheter ablation of atrial fibrillation in patients with cardiac amyloidosis and sarcoidosis: procedural findings and outcomes. Europace, 27(6). https://doi.org/10.1093/europace/euaf100
Vancouver
Oraii A, Hanumanthu BKJ, Petzl A, Liao TW, Afzalian A, Rodriguez-Queralto O, et al. Catheter ablation of atrial fibrillation in patients with cardiac amyloidosis and sarcoidosis: procedural findings and outcomes. Europace. 2025;27(6). doi:10.1093/europace/euaf100
BibTeX
@article{Oraii2025,
author = {Oraii, Alireza and Hanumanthu, Balaram Krishna J and Petzl, Adrian and Liao, Ting-Wei and Afzalian, Arian and Rodriguez-Queralto, Oriol and Chaumont, Corentin and Spears, Jenna and Markman, Timothy M and Hyman, Matthew C and Tschabrunn, Cory M and Guandalini, Gustavo and Enriquez, Andres and Shivamurthy, Poojita and Kumareswaran, Ramanan and Deo, Rajat and Ferrari, Victor A and Riley, Michael P and Lin, David and Callans, David J and Supple, Gregory E and Schaller, Robert D and Frankel, David S and Garcia, Fermin C and Nazarian, Saman and Dixit, Sanjay and Marchlinski, Francis E},
title = {Catheter ablation of atrial fibrillation in patients with cardiac amyloidosis and sarcoidosis: procedural findings and outcomes},
journal = {Europace},
year = {2025},
volume = {27},
number = {6},
doi = {10.1093/europace/euaf100}
}
EUVIMED